- New insights into diagnosis and treatment of secondary hypertension
- Great Debate: renal denervation is one of the pillars of management of resistant hypertension
- Navigating complex decision making: personalised care beyond the guidelines
- Preventing and treating hypertension beyond medications
- Every action counts in blood pressure control
- Hypertension care, reimagined: The Symplicity blood pressure procedure
- New drugs in the management of hypertension: global perspectives Joint session with the International Society of Hypertension (ISH)
- Management of hypertension guidelines: from development to implementation Joint session with the Hong Kong College of Cardiology (HKCC)
- Hypertension with cardiometabolic comorbidities: which drugs to select and which to avoid
- Towards better blood pressure control: policy and innovation in Asia Pacific - World Heart Federation (WHF) and Asian Pacific Society of Cardiology (APSC) joint session
- Heart-brain axis in cardiovascular disease
- Think managing hypertension is easy? Try outsmarting the experts
- Cutting to the Core - Hypertension
- Strategies for prevention and better outcomes in chronic kidney disease - Joint session with the European Renal Association (ERA)
- Harnessing digital innovations for prevention and treatment of hypertension
- Difficult to control hypertension: a practical approach in four steps - Joint session with the European Society of Hypertension (ESH)
- Natural disasters, human conflict, and social changes: impacts on cardiovascular health
- Improving equity in stroke prevention and treatment: focus on sex and ethnic differences
- Enemies of proper anticoagulant therapy
- Management of atrial fibrillation: a global perspective
- Great Debate: do we really need long-term cardiac rhythm monitoring after embolic stroke of unknown source?
- Evolution of anticoagulation therapy in patients with atrial fibrillation
- Brain injury following cardiovascular intervention: how to prevent, how to rescue
- Great Debates: stroke prevention in specific clinical scenarios
- Caring for multimorbid frail patients with atrial fibrillation
- Bridging worlds in stroke prevention: finding consensus between healthcare professionals for complex atrial fibrillation scenarios
- Heart-brain interaction in acute neurologic and cardiac events Joint session with the European Academy of Neurology (EAN)
- The bleeding brain: cardiologists and cerebral haemorrhage
- Thromboembolic events and stroke in TAVI
- Cardioembolic stroke with specific conditions
- Optimising atrial fibrillation detection and management in people after stroke - Joint session with the European Stroke Organisation (ESO)
Sessions :
- Cardiology Toolbox - Genetics for cardiologists
- Cardiomyopathies and genetics: challenging diagnoses
- Challenges in preventive cardiology and lipids
- Novel interventions and therapies to prevent sudden arrhythmic death
- Artificial intelligence tools to improve personalised medicine: a basic introduction for cardiologists with lessons learned from three EU projects
- Emerging therapeutic frontiers in cardiology: what does the future hold?
- ESC Geoffrey Rose Lecture in Population Sciences
- Novel disease mechanisms and therapeutic targets in cardiomyopathies
- Circulation: the full spectrum
- Advances in gene therapy and gene editing in the heart and vasculature
- Inflammation and the heart: myocarditis and beyond (3)
- Cardiomyopathies and genetics
- Nature Medicine: 2025 highlights
- A new era of sudden cardiac death prediction
- Translating genome-wide association studies (GWAS) into diagnostic and therapeutic targets for cardiovascular disease
- Myocarditis management in 2025 from a global perspective
- Clonal haematopoiesis of indeterminate potential: a novel cardiovascular risk factor
Discover the clinical cases, abstracts and posters
- Top 10 Papers 2025 in prevention, ischaemic heart disease, and interventional cardiology
- Navigating cardiovascular challenges in cancer care: real-world insights
- Imaging in cardio-oncology
- Harnessing innovation to mitigate cardiovascular risk in patients with cancer - Joint session with the European Society for Medical Oncology (ESMO)
- Optimising cardio-oncology care with multimodality imaging: practical approaches
- 2025 ESC Guidelines and Document overview
- 2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease
- The floor is yours: bring your questions on screening, diagnosis, and management of chronic coronary syndromes
- Cardiovascular diseases in older adults
- Guidelines in Practice: 2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease
- 2025 ESC Guidelines for the Management of Myocarditis and Pericarditis
- The key aspects of managing prevalent cardiovascular conditions
- 2025 ESC Guidelines for the Management of Myocarditis and Pericarditis: Ask the Task Force
- New levels of evidence for ESC Guidelines: better fit and higher standards
- Guidelines in Practice: 2025 ESC Guidelines for the Management of Myocarditis and Pericarditis
- 2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias
- 2025 ESC Guidelines for the Management of Cardiovascular Disease and Pregnancy
- 2025 ESC Guidelines for the Management of Cardiovascular Disease and Pregnancy: Ask the Task Force
- 2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias: Ask the Task Force
- Guidelines in Practice: 2025 ESC Guidelines for the Management of Cardiovascular Disease and Pregnancy
2025 ESC Consensus Statement on Mental Health and Cardiovascular Disease - Guidelines in Practice: 2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias
- 2025 ESC Consensus Statement on Mental Health and Cardiovascular Disease: Ask the Task Force
- Guidelines in Practice: 2025 ESC Consensus Statement on Mental Health and Cardiovascular Disease
Discover all type of sessions, clinical cases, abstracts and posters on the Guidelines
- What makes an atherosclerotic plaque vulnerable? novel perspectives
- Shunting forward: new insights, mechanisms, and the future of interatrial shunt devices in heart failure
- What you always wanted to know about OMICs: translating cutting-edge technology into clinical application
- Cardiac macrophages: emerging roles in cardiac pathophysiology and repair
- The nerve of it! new insights into cardioimmune neural interfaces
- Charting the course for personalised pulmonary arterial hypertension care
- Novel interventions and therapies to prevent sudden arrhythmic death
- The critical role of optimised transthyretin (TTR) stabilisation for improved ATTR-CM patient outcomes
- The Holy Grail: cardiac regeneration
- Atrial cardiomyopathy and fibrillation: a translational perspective
- ESC William Harvey Lecture in Basic Science
- An expert tour of the ATTR-CM therapeutic landscape and what it means for patients
- Vascular immunometabolism: emerging mechanisms and therapeutic opportunities
- Novel disease mechanisms and therapeutic targets in cardiomyopathies
- Beyond weight loss: cardiometabolic benefits of GLP-1 receptor agonists
- The intricate interplay between fat and the heart
- Impact of the environment (exposome) on cardiovascular health
- Vascular ageing: from mechanisms to therapeutic targets
- Translating genome-wide association studies (GWAS) into diagnostic and therapeutic targets for cardiovascular disease
- Prompt treatment of asymptomatic severe aortic stenosis - the case for action
- The landscape of rheumatic heart disease in the ASEAN region and beyond - Joint session with the Asean Federation of Cardiology (AFC)
- 2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease
- Intracoronary imaging: fancy pictures or favourable outcomes?
- 2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease: Ask the Task Force
- Aortic stenosis: when to intervene and how?
- ESC Andreas Grüntzig Lecture in Interventional Cardiology
- Guidelines in Practice: 2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease
- Innovations and breakthroughs in interventional cardiology - Joint session with the Cardiovascular Research Foundation (CRF)
- Heart team debates ESC/EACTS-VHD Guidelines throughout: mitral and tricuspid interventions in the spotlight
- Transforming the care of female and low-risk younger patients with aortic stenosis through guidelines
- Beyond stenting: optimising adjunctive pharmacotherapy for myocardial infarction
- Chronic thromboembolic pulmonary hypertension: Heart Team Summit
- ESC TV Roundtable - The future of organ bioprinting and artificial hearts
- Transcatheter mitral and tricuspid interventions in the East and West - Joint session with the Chinese Society of Cardiology (CSC)
- Management of moderate valvular heart disease
- ACT Global: can we catalyse a worldwide movement to improve rheumatic heart disease outcomes through data and collaboration - World Heart Federation (WHF) and Pan-African Society of Cardiology (PASCAR) joint session
- Artificial intelligence-supported coronary interventions: hype or hope?
- Unmet medical needs in valvular heart disease
- Challenges in the management of complex cardiovascular diseases - Joint session with the Cardiological Society of India (CSI)
- Cutting to the Core - Right heart catheterisation
- TAVI in challenging scenarios: what does the evidence tell us?
- How to get artificial intelligence to the bedside of aortic stenosis
- Microvascular dysfunction: bridging guidelines and practice in chronic coronary syndromes
- Guidelines in Practice: patient-centred decision-making for NSTEMI and multivessel disease
- Guidelines in Practice: how imaging guides management in native valve infective endocarditis
Our mission: To reduce the burden of cardiovascular disease.